SVWAG
KNSA icon

Sound View Wealth Advisors Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Sound View Wealth Advisors Group’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$850K Sell
13,296
-1,754
-12% -$91K 0.05% 215
2026
Q1 		$725K Buy
15,050
+258
+2% +$11.4K 0.05% 229
2025
Q4 		$610K Buy
14,792
+2,063
+16% +$82.8K 0.04% 250
2025
Q3 		$494K Buy
12,729
+224
+2% +$7.28K 0.03% 271
2025
Q2 		$346K Sell
12,505
-2,152
-15% -$54.8K 0.03% 324
2025
Q1 		$326K Buy
14,657
+568
+4% +$11.7K 0.03% 319
2024
Q4 		$279K Buy
14,089
+423
+3% +$9.65K 0.02% 355
2024
Q3 		$342K Buy
13,666
+3,024
+28% +$73.7K 0.03% 314
2024
Q2 		$199K Buy
+10,642
New +$199K 0.02% 354

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Sound View Wealth Advisors Group's KNSA Position: Q2 2026 in Review

Sound View Wealth Advisors Group reduced its Kiniksa Pharmaceuticals (KNSA) stake by 12% in Q2 2026, selling an estimated $91K and leaving 13,296 shares worth $850K. The position accounts for 0.05% of the portfolio, ranked #215.

Sound View Wealth Advisors Group first reported a position in KNSA in Q2 2024 and has held it in 9 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Sound View Wealth Advisors Group held 13,296 shares of Kiniksa Pharmaceuticals worth $850K as of Q2 2026.
  • Sound View Wealth Advisors Group sold 1,754 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $91K.
  • Kiniksa Pharmaceuticals made up 0.05% of Sound View Wealth Advisors Group's portfolio in Q2 2026, its #215 holding.
  • Sound View Wealth Advisors Group first reported a position in Kiniksa Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Sound View Wealth Advisors Group's 13F filing for Q2 2026, filed 11 Aug 2026.